InvestorsHub Logo
Followers 73
Posts 6211
Boards Moderated 0
Alias Born 05/01/2011

Re: eightisenough post# 227654

Monday, 11/18/2019 8:37:27 AM

Monday, November 18, 2019 8:37:27 AM

Post# of 425688
Dude, I think the label should be quite broad

But the FDA doesn't (normally) see things this way, and besides, they (AMRN and suppliers) can only make so much of this stuff.

We have done that exercise so many times here. There aren't enough anchovies in the sea to service the population that would benefit from this.

Over time as things evolve (and I mean 5-10 year timeframe) they will find new methods of generating supply, and broadening the population that routinely uses this stuff. By the time it goes generic, it'll get used like aspirin.

It's all good.

“The trick is in what one emphasizes. We either make ourselves miserable, or we make ourselves happy. The amount of work is the same.” Carlos Castaneda

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News